GLIOBLASTOMA MULTIFORME: A META-ANALYSIS OF DRIVER GENES, CURRENT DIAGNOSIS, AND TUMOR HETEROGENEITY

作者: Gabriel Emilio Herrera-Oropeza , Carla Angulo-Rojo , Santos Alberto Gástelum-López , Alfredo Varela-Echavarría , Maribel Hernández-Rosales

DOI: 10.1101/2020.10.19.20215467

关键词:

摘要: Abstract Glioblastoma (GBM) is the most aggressive and common brain cancer in adults with lowest life expectancy. The current neuro-oncology practice has incorporated genes involved key molecular events that drive GBM tumorigenesis as biomarkers to guide diagnosis design treatment. This study summarizes findings describing significant heterogeneity of at transcriptional genomic levels, emphasizing eighteen driver clinical relevance. A pattern was identified fitting stem cell model for ontogenesis, an up-regulation profile MGMT down-regulation ATRX, H3F3A, TP53, EGFR mesenchymal subtype. We also detected overexpression EGFR, NES, VIM, TP53 classical subtype MKi67 OLIG2 proneural In keeping this, we found a panel nine strong potential determine unique distribution somatic mutations young adult population, particularly related DNA repair chromatin remodeling, highlighting MGMT, IDH1. Our results revealed highly lesioned undergo differential regulation particular biological pathways patients. meta-analysis will help delineate future strategies use these markers decision-making medical routine.

参考文章(32)
Ivan Adzhubei, Daniel M. Jordan, Shamil R. Sunyaev, Predicting Functional Effect of Human Missense Mutations Using PolyPhen-2 Current protocols in human genetics. ,vol. 76, ,(2013) , 10.1002/0471142905.HG0720S76
Marc Aubry, Marie de Tayrac, Amandine Etcheverry, Anne Clavreul, Stéphan Saikali, Philippe Menei, Jean Mosser, From the core to beyond the margin: a genomic picture of glioblastoma intratumor heterogeneity. Oncotarget. ,vol. 6, pp. 12094- 12109 ,(2015) , 10.18632/ONCOTARGET.3297
Rui Li, Hailin Li, Wei Yan, Pei Yang, Zhaoshi Bao, Chuanbao Zhang, Tao Jiang, Yongping You, Genetic and clinical characteristics of primary and secondary glioblastoma is associated with differential molecular subtype distribution Oncotarget. ,vol. 6, pp. 7318- 7324 ,(2015) , 10.18632/ONCOTARGET.3440
Hiromichi Suzuki, Kosuke Aoki, Kenichi Chiba, Yusuke Sato, Yusuke Shiozawa, Yuichi Shiraishi, Teppei Shimamura, Atsushi Niida, Kazuya Motomura, Fumiharu Ohka, Takashi Yamamoto, Kuniaki Tanahashi, Melissa Ranjit, Toshihiko Wakabayashi, Tetsuichi Yoshizato, Keisuke Kataoka, Kenichi Yoshida, Yasunobu Nagata, Aiko Sato-Otsubo, Hiroko Tanaka, Masashi Sanada, Yutaka Kondo, Hideo Nakamura, Masahiro Mizoguchi, Tatsuya Abe, Yoshihiro Muragaki, Reiko Watanabe, Ichiro Ito, Satoru Miyano, Atsushi Natsume, Seishi Ogawa, Mutational landscape and clonal architecture in grade II and III gliomas Nature Genetics. ,vol. 47, pp. 458- 468 ,(2015) , 10.1038/NG.3273
Constantinos Alifieris, Dimitrios T. Trafalis, Glioblastoma multiforme: Pathogenesis and treatment Pharmacology & Therapeutics. ,vol. 152, pp. 63- 82 ,(2015) , 10.1016/J.PHARMTHERA.2015.05.005
Mel Greaves, Carlo C. Maley, Clonal evolution in cancer Nature. ,vol. 481, pp. 306- 313 ,(2012) , 10.1038/NATURE10762
A. P. Patel, I. Tirosh, J. J. Trombetta, A. K. Shalek, S. M. Gillespie, H. Wakimoto, D. P. Cahill, B. V. Nahed, W. T. Curry, R. L. Martuza, D. N. Louis, O. Rozenblatt-Rosen, M. L. Suva, A. Regev, B. E. Bernstein, Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma Science. ,vol. 344, pp. 1396- 1401 ,(2014) , 10.1126/SCIENCE.1254257
Ian F. Pollack, Sydney D. Finkelstein, Jeffrey Woods, Judith Burnham, Emiko J. Holmes, Ronald L. Hamilton, Allan J. Yates, James M. Boyett, Jonathan L. Finlay, Richard Sposto, Expression of p53 and prognosis in children with malignant gliomas. The New England Journal of Medicine. ,vol. 346, pp. 420- 427 ,(2002) , 10.1056/NEJMOA012224
Orieta Celiku, Seth Johnson, Shuping Zhao, Kevin Camphausen, Uma Shankavaram, Visualizing Molecular Profiles of Glioblastoma with GBM-BioDP PLoS ONE. ,vol. 9, pp. e101239- ,(2014) , 10.1371/JOURNAL.PONE.0101239
Jason T. Huse, Eric C. Holland, Targeting brain cancer: advances in the molecular pathology of malignant glioma and medulloblastoma Nature Reviews Cancer. ,vol. 10, pp. 319- 331 ,(2010) , 10.1038/NRC2818